ZTS

#225
ZOETIS INC.
131.1300
+1.08%
Secteur:
Base:
Devise de Profit:
Range quotidien
130.3700
132.3000
Range Annuel
115.2500
147.9000
Changement quotidien
+1.08%
Changement Mensuel
+5.46%
Evolution sur 6 mois
-10.38%
Changement Annuel
-10.38%
Clôture Précédente
129.7300
Open
131.9700
Bid
Ask
Low
130.3700
High
132.3000
Volume
2 458
Open full chart

Financials

Overview Relevé Statistics Dividends
Quarterly Annual
  • Market Capitalization 58.1487 B
  • Employee 15 K
  • Founded N/A
  • CEO Kristin C. Peck
  • Website www.zoetis.com
  • Headquarter New Jersey, United States
  • FIGI BBG0039320N9
  • Industry Technology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
20.9
Price to sales ratio
5.9
Dividends per share
2.03
Dividend yield %
1.61

Zoetis Inc Class A

Zoetis Inc. is an American drug company, the world's largest producer of medicine and vaccinations for pets and livestock. The company was a subsidiary of Pfizer, the world's largest drug maker, but with Pfizer's spinoff of its 83% interest in the firm it is now a completely independent company. The company directly markets its products in approximately 45 countries, and sells them in more than 100 countries. Operations outside the United States accounted for 50% of the total revenue. Contemporaneous with the spinoff in June 2013 S&P Dow Jones Indices announced that Zoetis would replace First Horizon National Corporation in the S&P 500 stock market index.

Nouvelles